LPL Financial’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.29M Sell
418,640
-110,142
-21% -$477K ﹤0.01% 3935
2025
Q4
$1.88M Sell
528,782
-5,537
-1% -$33.9K ﹤0.01% 3476
2025
Q3
$4.76M Sell
534,319
-24,023
-4% -$244K ﹤0.01% 2511
2025
Q2
$5.15M Buy
558,342
+11,716
+2% +$100K ﹤0.01% 2283
2025
Q1
$4.69M Buy
546,626
+452,723
+482% +$4.27M ﹤0.01% 2202
2024
Q4
$1.01M Buy
93,903
+25,048
+36% +$193K ﹤0.01% 3482
2024
Q3
$391K Buy
68,855
+15,550
+29% +$89.7K ﹤0.01% 4216
2024
Q2
$225K Sell
53,305
-5,775
-10% -$23.4K ﹤0.01% 4478
2024
Q1
$301K Buy
59,080
+200
+0.3% +$1.13K ﹤0.01% 4196
2023
Q4
$548K Buy
58,880
+2,940
+5% +$20.2K ﹤0.01% 3587
2023
Q3
$366K Sell
55,940
-4,965
-8% -$39.5K ﹤0.01% 3741
2023
Q2
$495K Buy
60,905
+11,740
+24% +$101K ﹤0.01% 3456
2023
Q1
$421K Buy
49,165
+5,525
+13% +$55.1K ﹤0.01% 3474
2022
Q4
$404K Buy
43,640
+3,800
+10% +$40.6K ﹤0.01% 3437
2022
Q3
$411K Buy
39,840
+2,410
+6% +$25.4K ﹤0.01% 3326
2022
Q2
$375K Buy
37,430
+11,185
+43% +$106K ﹤0.01% 3444
2022
Q1
$323K Buy
26,245
+10,250
+64% +$126K ﹤0.01% 3524
2021
Q4
$277K Sell
15,995
-4,693
-23% -$89.2K ﹤0.01% 3736
2021
Q3
$371K Buy
20,688
+8,913
+76% +$177K ﹤0.01% 3475
2021
Q2
$269K Buy
+11,775
New +$174K ﹤0.01% 3670

Other funds holding AVXL